ADHD in the News 2023-11-16
Can’t Think, Can’t Remember: More Americans Say They’re in a Cognitive Fog
There are more Americans who say they have serious cognitive problems — with remembering, concentrating or making decisions — than at any time in the last 15 years, data from the Census Bureau shows. The increase started with the pandemic: The number of working-age adults reporting “serious difficulty” thinking has climbed by an estimated one million people.
ADHD drugs delay bone healing in children, UB researchers report
Children taking psychostimulant drugs prescribed for psychiatric disorders including attention deficit hyperactivity disorder (ADHD) who experience a common childhood fracture take longer to heal than children who don’t take these drugs, UB researchers report. The findings were published in the Journal of Pediatric Orthopaedics B in September.
Substituting ADHD Medications During the Stimulant Shortage
KEY POINTS: The ADHD stimulant medication shortage is continuing. Understanding ADHD medications can help you make rational choices if your current medication is unavailable. There are actually a lot of choices out there for patients.
Early-life stress changes more genes in the brain than a head injury
A surprising thing happened when researchers began exploring whether early-life stress compounds the effects of a childhood head injury on health and behavior later in life: In an animal study, stress changed the activation level of many more genes in the brain than were changed by a bump to the head.
Maternal metabolic conditions linked to children’s neurodevelopmental risks, study shows
In a recent study published in BMC Medicine, researchers quantified the extent to which obstetric and neonatal factors mediated the relationship between three maternal metabolic conditions, pregestational diabetes mellitus (PGDM), gestational diabetes (GDM), obesity, and neurodevelopmental conditions (NDCs) in children.
Adults With Migraine Have Higher Prevalence of ADHD and Impulsivity Symptoms
Adults with migraine have a higher prevalence of attention-deficit/hyperactivity disorder (ADHD) symptoms and a higher impulsive personality trait score, according to results of a study published in the Journal of Attention Disorders. While it has been commonly reported that individuals with ADHD have an increased occurrence of migraine, the inverse of this relationship — ADHD symptoms in migraine patients — has not been thoroughly explored.
Ritalin research: This “smart drug” can impair or enhance your creativity depending on your brain chemistry
New research provides evidence that individual differences in dopamine levels in the brain’s putamen region can influence how methylphenidate, a widely used “smart drug,” affects our creative thinking processes. The findings, published in Neuropsychopharmacology, indicate that the use of methylphenidate can impair specific forms of creativity in those with low baseline dopamine levels.
Objectively Measured Sleep in ADHD
What is the impact of ADHD on sleep? Researchers performed a systematic review and meta-analysis of objectively measured sleep in children and adolescents with ADHD.
New research explores the unique effects of ADHD medications on Drosophila brain cells
In a recent study published in Molecular Psychiatry, researchers from China examined the effect of two drugs used for the treatment of attention-deficit/hyperactivity disorder (ADHD)— methylphenidate (MPH) and atomoxetine (ATX)— on the Drosophila melanogaster brain at single-cell resolution.
ADHD medication shortage impacting Garner pharmacy
GARNER, N.C. (WNCN) — Pharmacists at White Oak Pharmacy in Garner say some medications just aren’t coming in the door, specifically ones for ADHD patients. “Focalin and Concerta, those remain on backorder, which is a real problem for a lot of children in school right now that take those,” said owner Melissa Illig.
3 Powerful Ways Kids With ADHD Can Stand Up To Bullies
Recognition, response, and resilience will get them far in life.
People With Suspected ADHD Are Facing A Crisis In The UK
4.1 million Brits are not treating their conditions due to NHS waiting lists and a lack of accessible treatment.